Groupe la Francaise’s Celularity CELU Stock Holding History

Groupe la Francaise’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,000	Closed	-$31.1K	–	518
2025 Q3	$31.1K	Buy	+17,000	New	+$47.6K	﹤0.01%	495

Other funds holding CELU

CVSC

C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Groupe la Francaise's CELU Position: Q4 2025 in Review

Groupe la Francaise sold out of Celularity (CELU) in Q4 2025, closing a stake of 17,000 shares — an estimated $31.1K sold.

Groupe la Francaise first reported a position in CELU in Q3 2025 and held it in 1 quarter. The position peaked at $31.1K in Q3 2025. 36 funds tracked by Wall St. Rank hold CELU as of Q4 2025.

Groupe la Francaise reported no remaining Celularity position as of Q4 2025 after selling out during the quarter.
Groupe la Francaise sold 17,000 Celularity shares in Q4 2025, an estimated $31.1K.
Groupe la Francaise first reported a position in Celularity in Q3 2025 and held it in 1 quarter.
Groupe la Francaise's Celularity position peaked at $31.1K in Q3 2025.
36 funds tracked by Wall St. Rank held Celularity as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.